About US
Contact us
-
Bayer set to buy Schiff Nutrition International for $1.2bnGerman drugmaker Bayer has agreed to buy Schiff Nutrition International for approximately US$1.2 billion, the company has confirmed. Schiff is a leading vitamin manufacturer in the US, with its portf2012/11/1
-
More Sharing ServicesShare: Share on facebookShare on twitterShare on linkedinShare on sinaweiboShare on baiduShare on emailShare on printWatson sells Rugby OTC products and trademarks to Major PharmaceuticalsWatson Pharmaceuticals has sold its Rugby over-the-counter (OTC) pharmaceutical products and trademarks to Major Pharmaceuticals, a division of the Harvard Drug Group. The transaction was valued at a2012/11/1
-
Bayer set to buy Schiff Nutrition International for $1.2bnGerman drugmaker Bayer has agreed to buy Schiff Nutrition International for approximately US$1.2 billion, the company has confirmed. Schiff is a leading vitamin manufacturer in the US, with its portf2012/10/31
-
Sanofi to continue developing Prednisporin under sub-licencing agreementSanofi has announced in its latest quarterly financial update that the company intends to continue developing Prednisporin under the terms of a sublicense agreement with a third party. Prednisporin i2012/10/31
-
Organisational structure 'key to pharma compliance'With only a quarter of leading pharmaceutical companies having centralised their compliance departments, new research suggests that organisational structure is crucial to improving these efforts. Acc2012/10/30
-
'Slight decline' in pharmaceutical M&A activityThe last 18 months has seen a slight decline in pharmaceutical merger and acquisition (M&A) activity, following steady levels since 2008, a report has revealed.Research by intelligence firm Irving2012/10/30
-
Canada joins in on Novartis vaccine suspensionAdd Canada to the growing list of countries weighing in against Novartis' ($NVS) flu vaccines.Health Canadasaid it would suspend the shots, following similar moves by European regulators, because of c2012/10/29
-
Pfizer reps to bear brunt of Canadian layoffsMore job cuts at Pfizer ($PFE). The world's biggest drugmaker is shedding 300 from its Canadian workforce, or about 11% of its employees in the country. Hardest hit will be sales and marketing, partic2012/10/29
-
Novo's new insulin Tresiba to face tough questions from FDA panelLast week, the future of Novo Nordisk's newinsulindrug Tresiba looked very bright. Today, not so much.A week ago, theEuropean Medicines Agency(EMA) recommended the long-acting insulin for approval, an2012/10/26
-
Germany, France join crowd withdrawing Novartis vaccinesMuch of the EU crowd has decided to jump on the bandwagon, pulling some of Novartis' ($NVS)flu vaccinesfrom the market because there have been reports of particulates in some vials. No problems have b2012/10/26